We have a Non-cGMP API starting material company with operations in Jaipur, India and Birmingham, Alabama. 14 years old, $33 Million in 2021 sales, $20 million EBITDA. 120 staff, long term relationships with US / Japanese client base. I’m looking for x9 EBITDA.
Private-Equity owned, Phase III plasma-derived therapeutic company is ready to build the commercial facility with One Million Liter annual capacity, in Dallas Texas, with $1.5 Billion in future annual revenue. We are looking for $60-240 Million depending on the investment levels.
Self-amplifying RNA (saRNA) Virtual Biotech seeks VC investment to develop a pipeline of RNA therapeutics and vaccines. We are looking for $6-10 million for pre-series A investment.
University-owned high-throughput, nanoparticle processing technology company. Experience with inline processing and concentrating systems provides unique capabilities, they offer a robust, continuous platform for nanoparticle concentration and sterile filtration. We are looking for $1-3 million for seed investment.
Oral Solid Dose (OSD) Tablets & Capsules facility, 45 minutes from Boston, with $20 million in facility value / equipment. Hand full of active customers, $2-3 Million in annual sales, break even EBITDA, 40,000 Sqft, 2,500 cGMP, DEA license, and FDA approved. Limited staff of around 10. We are looking for $8 million for the real estate & business.